Revenue | ₹1.65Cr |
Net Profits | ₹-2.59Cr |
Net Profit Margins | -156.97% |
Vista Pharmaceuticals Ltd’s revenue fell -34% since last year same period to ₹1.65Cr in the Q2 2025-2026. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated 8.55% jump in its revenue since last 3-months.
Vista Pharmaceuticals Ltd’s net profit fell -167.01% since last year same period to ₹-2.59Cr in the Q2 2025-2026. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated -100.78% fall in its net profits since last 3-months.
Vista Pharmaceuticals Ltd’s net profit margin fell -304.56% since last year same period to -156.97% in the Q2 2025-2026. On a quarterly growth basis, Vista Pharmaceuticals Ltd has generated -84.96% fall in its net profit margins since last 3-months.
The revenue for Vista Pharmaceuticals Ltd in the Q2 results 2025 was ₹1.65Cr.
The net profit for Vista Pharmaceuticals Ltd in the Q2 results 2025 was ₹-2.59Cr.
The net profit margin for Vista Pharmaceuticals Ltd in the Q2 results 2025 was -156.97%.
The revenue for Vista Pharmaceuticals Ltd in the Q2 results 2024 was ₹2.50Cr.
The net profit for Vista Pharmaceuticals Ltd in the Q2 results 2024 was ₹0.97Cr.
The net profit margin for Vista Pharmaceuticals Ltd in the Q2 results 2024 was -38.80%.